Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy
Authors:
- Howard S SmithHSHoward S Smith
- Robert L BarkinRBRobert L Barkin
- 1 July 2010
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 17 (4) , 418-439
Abstract
Fibromyalgia is a complex condition that is characterized by chronic widespread pain and multiple other symptoms, including fatigue, sleep disturbances, cognitive dysfunction, stiffness, and depressive episodes. Fibromyalgia may coexist and/or overlap with other conditions that may involve central sensitivity, including chronic fatigue syndrome, irritable bowel syndrome, irritable bladder syndrome or interstitial cystitis, and temporomandibular disorder. The pathophysiology of fibromyalgia remains uncertain but is believed to be partly the result of central systems affecting afferent processing as well as impaired endogenous pain-inhibitory systems. Abnormal central nociceptive processing may contribute to fibromyalgia, producing heightened responses to various noxious stimuli with resulting mechanical hyperalgesia. Fibromyalgia remains a clinical diagnosis. There has been a recent paradigm shift away from requiring 11 or more out of 18 tender points and instead focusing on the presence of chronic widespread pain as well as symptoms of fatigue, unrefreshed sleep, and other somatic complaints. Although there is no known cure for fibromyalgia, multidisciplinary team efforts using combined treatment approaches, including patient education, aerobic exercise, cognitive behavioral therapy, and pharmacologic therapies (serotonin norepinephrine reuptake inhibitors [eg, duloxetine, milnacipran] and alpha 2-delta receptor ligands [eg, pregabalin]) may improve symptoms as well as function of patients with fibromyalgia.Keywords
This publication has 83 references indexed in Scilit:
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Pool exercise for patients with fibromyalgia or chronic widespread pain: A randomized controlled trial and subgroup analysesJournal of Rehabilitation Medicine, 2009
- A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgiaInternational Journal of General Medicine, 2008
- Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trialClinical Therapeutics, 2008
- Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trialArthritis Research & Therapy, 2008
- A six‐month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgiaArthritis & Rheumatism, 2008
- An internet survey of 2,596 people with fibromyalgiaBMC Musculoskeletal Disorders, 2007
- The burden of musculoskeletal diseases in the general population of Spain: results from a national surveyAnnals of the Rheumatic Diseases, 2001
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990